Research Paper Volume 16, Issue 10 pp 9047—9071
Targeting PRKDC activates the efficacy of antitumor immunity while sensitizing to chemotherapy and targeted therapy in liver hepatocellular carcinoma
Figure 8. PRKDC knockdown induced cell death, EMT, and halted the cell cycle in LIHC. (A, B) Relative cell death percentages in Huh-7 or Hep-3B cells using trypan blue staining. (C, D) Protein level of apoptosis related markers in Huh-7 or Hep-3B cells. (E, F) Protein level of EMT related markers in Huh-7 or Hep-3B cells. (G–J) Cell cycle analysis between PRKDC knockdown and negative control groups in Huh-7 or Hep-3B cells using flow cytometry.